• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

莱伯先天性黑蒙:与基因型的临床关联、基因治疗试验进展及未来方向

Leber congenital amaurosis: clinical correlations with genotypes, gene therapy trials update, and future directions.

作者信息

Chung Daniel C, Traboulsi Elias I

机构信息

F.M. Kirby Center for Molecular Ophthalmology, Scheie Eye Institute, University of Pennsylvania, Philadelphia, Pennsylvania.

出版信息

J AAPOS. 2009 Dec;13(6):587-92. doi: 10.1016/j.jaapos.2009.10.004.

DOI:10.1016/j.jaapos.2009.10.004
PMID:20006823
Abstract

Leber congenital amaurosis comprises a group of early onset childhood retinal dystrophies, characterized by vision loss, nystagmus, and severe retinal dysfunction. To date, 15 causative genes have been identified that account for the heterogeneous presentation and clinical course. Knowledge of key aspects of phenotype and clinical course can contribute to the determination of a precise genetic etiology using genetic testing. Gene-based therapies are emerging, and knowledge of a patient's genotype is essential. A review of clinical presentation and disease course, their correlation to specific genotypes, and underlying physiological mechanisms, coupled with the latest results of human gene therapy trials, will assist the clinician in patient diagnosis and counseling.

摘要

莱伯先天性黑矇症是一组儿童期早发性视网膜营养不良症,其特征为视力丧失、眼球震颤和严重的视网膜功能障碍。迄今为止,已鉴定出15个致病基因,这些基因导致了其临床表现和病程的异质性。了解表型和病程的关键方面有助于通过基因检测确定精确的遗传病因。基于基因的疗法正在兴起,了解患者的基因型至关重要。对临床表现和疾病病程、它们与特定基因型的相关性以及潜在生理机制的综述,再结合人类基因治疗试验的最新结果,将有助于临床医生对患者进行诊断和咨询。

相似文献

1
Leber congenital amaurosis: clinical correlations with genotypes, gene therapy trials update, and future directions.莱伯先天性黑蒙:与基因型的临床关联、基因治疗试验进展及未来方向
J AAPOS. 2009 Dec;13(6):587-92. doi: 10.1016/j.jaapos.2009.10.004.
2
My child has Leber congenital amaurosis: why is he/she not eligible for gene therapy trials?
J AAPOS. 2009 Dec;13(6):533-4. doi: 10.1016/j.jaapos.2009.09.006.
3
The phenotype of Severe Early Childhood Onset Retinal Dystrophy (SECORD) from mutation of RPE65 and differentiation from Leber congenital amaurosis.RPE65 基因突变致严重婴幼儿期起病的视网膜色素变性表型及其与莱伯先天性黑矇的鉴别。
Invest Ophthalmol Vis Sci. 2011 Jan 5;52(1):292-302. doi: 10.1167/iovs.10-6106.
4
Available Evidence on Leber Congenital Amaurosis and Gene Therapy.关于莱伯先天性黑蒙和基因治疗的现有证据。
Semin Ophthalmol. 2017;32(1):14-21. doi: 10.1080/08820538.2016.1228383. Epub 2016 Sep 29.
5
Seeing is believing: gene therapy shows promise for ocular disorders.眼见为实:基因疗法有望治疗眼部疾病。
JAMA. 2010 Oct 13;304(14):1543-5. doi: 10.1001/jama.2010.1412.
6
Clinical gene therapy for the treatment of RPE65-associated Leber congenital amaurosis.用于治疗 RPE65 相关莱伯先天性黑矇的临床基因治疗。
Expert Opin Biol Ther. 2011 Mar;11(3):429-39. doi: 10.1517/14712598.2011.557358.
7
Leber congenital amaurosis/early-onset severe retinal dystrophy: clinical features, molecular genetics and therapeutic interventions.莱伯先天性黑蒙/早发性严重视网膜营养不良:临床特征、分子遗传学及治疗干预措施
Br J Ophthalmol. 2017 Sep;101(9):1147-1154. doi: 10.1136/bjophthalmol-2016-309975. Epub 2017 Jul 8.
8
Gene augmentation trials using the Rpe65-deficient dog: contributions towards development and refinement of human clinical trials.使用Rpe65基因缺陷犬的基因增强试验:对人类临床试验发展与完善的贡献
Adv Exp Med Biol. 2012;723:177-82. doi: 10.1007/978-1-4614-0631-0_24.
9
Molecular anthropology meets genetic medicine to treat blindness in the North African Jewish population: human gene therapy initiated in Israel.分子人类学与基因医学相遇,为北非犹太人群体治疗失明:以色列启动人类基因治疗。
Hum Gene Ther. 2010 Dec;21(12):1749-57. doi: 10.1089/hum.2010.047. Epub 2010 Nov 3.
10
Gene therapy for Leber congenital amaurosis: advances and future directions.Leber 先天性黑矇的基因治疗:进展与未来方向。
Graefes Arch Clin Exp Ophthalmol. 2012 Aug;250(8):1117-28. doi: 10.1007/s00417-012-2028-2. Epub 2012 May 29.

引用本文的文献

1
Determination of the Population Frequency of Monoallelic and Biallelic Predicted Pathogenic RPE65 Variants in a Normal Database.正常数据库中预测的单等位基因和双等位基因致病性RPE65变体的群体频率测定
Invest Ophthalmol Vis Sci. 2025 Aug 1;66(11):73. doi: 10.1167/iovs.66.11.73.
2
Mettl3-Mediated m6A Modification is Essential for Visual Function and Retinal Photoreceptor Survival.Mettl3介导的m6A修饰对于视觉功能和视网膜光感受器存活至关重要。
Invest Ophthalmol Vis Sci. 2024 Dec 2;65(14):40. doi: 10.1167/iovs.65.14.40.
3
IQCB1 (NPHP5)-Retinopathy: Clinical and Genetic Characterization and Natural History.
IQCB1(NPHP5)相关性视网膜病变:临床与遗传学特征及自然病史
Am J Ophthalmol. 2024 Aug;264:205-215. doi: 10.1016/j.ajo.2024.03.009. Epub 2024 Mar 23.
4
Frameshift Variant in in Cirneco dell'Etna Dogs with Retinopathy and Tremors.Cirneco dell'Etna 犬视网膜病变和震颤中的 移码变异。
Genes (Basel). 2024 Feb 13;15(2):238. doi: 10.3390/genes15020238.
5
Ocular manifestations of renal ciliopathies.肾脏纤毛病的眼部表现。
Pediatr Nephrol. 2024 May;39(5):1327-1346. doi: 10.1007/s00467-023-06096-5. Epub 2023 Aug 30.
6
Therapeutic applications of CRISPR/Cas9 gene editing technology for the treatment of ocular diseases.CRISPR/Cas9 基因编辑技术在眼部疾病治疗中的治疗应用。
FEBS J. 2023 Nov;290(22):5248-5269. doi: 10.1111/febs.16771. Epub 2023 Mar 27.
7
Novel CRB1 pathogenic variant in Chuuk families with Leber congenital amaurosis.楚克家族中的莱伯先天性黑矇症的新型 CRB1 致病性变异。
Am J Med Genet A. 2023 Apr;191(4):1007-1012. doi: 10.1002/ajmg.a.63108. Epub 2023 Jan 3.
8
Ocular Gene Therapy: A Literature Review with Special Focus on Immune and Inflammatory Responses.眼部基因治疗:特别关注免疫和炎症反应的文献综述
Clin Ophthalmol. 2022 Jun 3;16:1753-1771. doi: 10.2147/OPTH.S364200. eCollection 2022.
9
Clinical and genetic spectrums of 413 North African families with inherited retinal dystrophies and optic neuropathies.413 个北非遗传性视网膜病变和视神经病变家系的临床和遗传谱。
Orphanet J Rare Dis. 2022 May 12;17(1):197. doi: 10.1186/s13023-022-02340-7.
10
Clinical and genetic heterogeneity of primary ciliopathies (Review).原发性纤毛病的临床和遗传异质性(综述)。
Int J Mol Med. 2021 Sep;48(3). doi: 10.3892/ijmm.2021.5009. Epub 2021 Jul 19.